InvestorsHub Logo
Followers 884
Posts 80769
Boards Moderated 2
Alias Born 01/09/2006

Re: None

Friday, 01/13/2017 11:59:26 AM

Friday, January 13, 2017 11:59:26 AM

Post# of 3063
"This is a first of its kind study, confirming PetLife’s in-house research on Venenotherapy, with Blue Scorpion venom, having no toxic side effects."

This is great $PTLF news. Science results coming in,

http://www.otcmarkets.com/stock/PTLF/news/PetLife-Pharmaceuticals-reports-the-First-of-Three-Preclinical-Studies-in-their-pre-INAD-Process-for-Vitalzul---nbsp-Blue-Scorpion-Venom-Toxicity-Study-Results-Show-No-Adverse-Reactions-across-Multiple-Dosing-Levels--nbsp-?id=148277&b=y

Buy it, trade it, hold it, ignore it... do whatever your want, just
don't do it because of what I say.